Phenotypes of antibody-mediated rejection in organ transplants

Transplant International

Volumn 25, Issue 6, 2012, Pages 611-622

  Mengel, Michael ^a   Husain, Sufia ^a   Hidalgo, Luis ^a   Sis, Banu ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

antibody mediated rejection; Banff; C4d; diagnostics; pathology; transplantation

Indexed keywords

ALLOANTIBODY; ANTIBODY; COMPLEMENT COMPONENT C4D; DONOR SPECIFIC ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ANTIBODY MEDIATED REJECTION; CAPILLARY; CONFERENCE PAPER; DIAGNOSTIC VALUE; GLOMERULITIS; GLOMERULONEPHRITIS; GRAFT REJECTION; HEART TRANSPLANTATION; HLA SYSTEM; HUMAN; IMMUNE DEFICIENCY; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY TUBULE CAPILLARY; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PHENOTYPE; PRIORITY JOURNAL; SINGLE ANTIGEN BEAD ASSAY; T CELL MEIDATED REJECTION;

ACUTE DISEASE; BIOLOGICAL MARKERS; BLOOD GROUP INCOMPATIBILITY; CHRONIC DISEASE; COMPLEMENT C4B; DIAGNOSIS, DIFFERENTIAL; GRAFT REJECTION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION; PEPTIDE FRAGMENTS; PHENOTYPE; T-LYMPHOCYTES;

EID: 84861190788     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01484.x     Document Type: Conference Paper

References (85)

1. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520.
2. Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure 1. Transplant 2010; 90: 68.
3. Colvin RB, Nickeleit V,. Renal transplant pathology. In:, Charles Jennette J, Olsen JL, Schwarz MM, Silva Fred C, eds. Heptinstall's Pathology of the Kidney, 6th edn. Philadelphia: Lippincott Williams & Wilkins, 2007: 1347-1490.
4. Williams GM, Hume DM, Hudson RP, Morris PJ, Kano K, Milgrom F,. Hyperacute renal-homograft rejection in man. N Engl J Med 1968; 279: 611.
5. Halloran PF, de Freitas DG, Einecke G, et al. An integrated view of molecular changes, histopathology, and outcomes in kidney transplants. Am J Transplant 2010; 10: 2223.
6. Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS,. The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplant 1990; 49: 85.
7. Halloran PF, Schlaut J, Solez K, Srinivasa NS,. The significance of the anti-class I response II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplant 1992; 53: 550.
8. Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF,. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Transplant 1996; 61: 1586.
9. Feucht HE, Schneeberger H, Hillebrand G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333.
10. Collins AB, Schneeberger EE, Pascual MA, et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 2208.
11. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
12. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.
13. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753.
14. Seemayer CA, Gaspert A, Nickeleit V, Mihatsch MJ,. C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques. Nephrol Dial Transplant 2007; 22: 568.
15. Sis B, Jhangri GS, Riopel J, et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 2011 (In press).
16. Batal I, Lunz III JG, Aggarwal N, et al. A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant 2010; 10: 2442.
17. Sis B, Einecke G, Chang J, et al. Cluster analysis of lesions in kidney transplant biopsies: Microcirculation changes, tubulointerstitial inflammation, and scarring. Am J Transplant 2010; 10: 421.
18. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ,. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242.
19. Furness PN, Taub N,. International variation in the interpretation of renal transplant biopsies: Report of the CERTPAP Project. Kidney Int 2001; 60: 1998.
20. Gibson IW, Gwinner W, Brocker V, et al. Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 2008; 8: 819.
21. Mengel M, Sis B, Haas M, et al. Banff 2011 Meeting Report: new concepts in antibody-mediated rejection. Am J Transplant 2012; 12: 563.
22. Haas M, Rahman MH, Racusen LC, et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant 2006; 6: 1829.
23. Fidler ME, Gloor JM, Lager DJ, et al. Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. Am J Transplant 2004; 4: 101.
24. Mengel M, Bogers J, Bosmans JL, et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant 2005; 5: 1050.
25. Moreso F, Carrera M, Goma M, et al. Early subclinical rejection as a risk factor for late chronic humoral rejection. Transplant 2012; 93: 41.
26. Kikic Z, Regele H, Nordmeyer V, et al. Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsies. Transplant 2011; 91: 440.
27. Loupy A, Hill GS, Suberbielle C, et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 2011; 11: 56.
28. Nickeleit V, Mihatsch MJ,. Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol Dial Transplant 2003; 18: 2232.
29. Leffell MS, Zachary AA,. Anti-allograft antibodies: some are harmful, some can be overcome, and some may be beneficial. Discov Med 2010; 9: 478.
30. Bray RA, Nickerson PW, Kerman RH, Gebel HM,. Evolution of HLA antibody detection: technology emulating biology. Immunol Res 2004; 29: 41.
31. Gebel HM, Bray RA,. The evolution and clinical impact of human leukocyte antigen technology. Curr Opin Nephrol Hypertens 2010; 19: 598.
32. Martin L, Guignier F, Mousson C, Rageot D, Justrabo E, Rifle G,. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplant 2003; 76: 395.
33. Kosmoliaptsis V, O'Rourke C, Bradley JA, Taylor CJ,. Improved Luminex-based human leukocyte antigen-specific antibody screening using dithiothreitol-treated sera. Hum Immunol 2010; 71: 45.
34. Zachary AA, Lucas DP, Detrick B, Leffell MS,. Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. Hum Immunol 2009; 70: 496.
35. Stegall MD, Diwan T, Raghavaiah S, et al. Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant 2011; 11: 2405.
36. Chen G, Sequeira F, Tyan DB,. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Hum Immunol 2011; 72: 849.
37. Bartel G, Wahrmann M, Exner M, et al. In vitro detection of C4d-fixing HLA alloantibodies: associations with capillary C4d deposition in kidney allografts. Am J Transplant 2008; 8: 41.
38. Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9: 2561.
39. Mauiyyedi S, Pelle PD, Saidman S, et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574.
40. Regele H, Bohmig GA, Habicht A, et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 2371.
41. Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518.
42. Hill GS, Nochy D, Bruneval P, et al. Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. J Am Soc Nephrol 2011; 22: 975.
43. Sijpkens YW, Joosten SA, Wong MC, et al. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004; 65: 2409.
44. Sis B, Campbell PM, Mueller T, et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7: 1743.
45. Lerut E, Naesens M, Kuypers DR, Vanrenterghem Y, Van Damme B,. Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year. Transplant 2007; 83: 1416.
46. Jabs WJ, Sedlmeyer A, Ramassar V, et al. Heterogeneity in the evolution and mechanisms of the lesions of kidney allograft rejection in mice. Am J Transplant 2003; 3: 1501.
47. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007; 7: 2124.
48. Gloor JM, Cosio FG, Rea DJ, et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006; 6: 1841.
49. Sellares J, De Freitas D, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and non-adherence. Am J Transplant 2012; 12: 388.
50. El ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9: 527.
51. Cosio FG, Gloor JM, Sethi S, Stegall MD,. Transplant glomerulopathy. Am J Transplant 2008; 8: 492.
52. Cosio FG, Lager DJ, Lorenz EC, Amer H, Gloor JM, Stegall MD,. Significance and implications of capillaritis during acute rejection of kidney allografts. Transplant 2010; 89: 1088.
53. Monga G, Mazzucco G, Novara R, Reale L,. Intertubular capillary changes in kidney allografts: an ultrastructural study in patients with transplant glomerulopathy. Ultrastruct Pathol 1990; 14: 201.
54. Monga G, Mazzucco G, Messina M, Motta M, Wuaranta S, Novara R,. Intertubular capillary changes in kidney allografts: a morphologic investigation on 61 renal specimens. Mod Pathol 1992; 5: 125.
55. Ivanyi B, Fahmy H, Brown H, Szenohradszky P, Halloran PF, Solez K,. Peritubular capillaries in chronic renal allograft rejection: a quantitative ultrastructural study. Hum Pathol 2000; 31: 1129.
56. Drachenberg CB, Steinberger E, Hoehn-Saric E, et al. Specificity of intertubular capillary changes: comparative ultrastructural studies in renal allografts and native kidneys. Ultrastruct Pathol 1997; 21: 227.
57. Haas M, Montgomery RA, Segev DL, et al. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 2007; 7: 576.
58. Dinavahi R, George A, Tretin A, et al. Antibodies reactive to non-HLA antigens in transplant glomerulopathy. J Am Soc Nephrol 2011; 22: 1168.
59. Joosten SA, Sijpkens YW, Van HV, Trouw LA, et al. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. Am J Transplant 2005; 5: 383.
60. Baid-Agrawal S, Farris III AB, Pascual M, et al. Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int 2011; 80: 879.
61. Cosio FG, Sedmak DD, Henry ML, et al. The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients. Transplant 1996; 62: 1054.
62. Akalin E, Dinavahi R, Dikman S, et al. Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol 2007; 2: 1261.
63. Al Aly Z, Yalamanchili P, Cortese C, Salinas-Madriga L, Bastani B,. C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: an uncommon finding. Transpl Int 2005; 18: 800.
64. + activated T cells in chronic allograft nephropathy with transplant glomerulopathy. Am J Transplant 2003; 3: 1116.
65. Sis B, Jhangri G, Bunnag S, Allanach K, Kaplan B, Halloran PF,. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312.
66. Sis B, Halloran PF,. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 2010; 15: 42.
67. Yamakuchi M, Kirkiles-Smith NC, Ferlito M, et al. Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc Natl Acad Sci USA 2007; 104: 1301.
68. Morrell CN, Murata K, Swaim AM, et al. In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody. Circ Res 2008; 102: 777.
69. Hidalgo LG, Sis B, Sellares J, et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 2010; 10 1812.
70. Osasan S, Sellares J, de Freitas DG, et al. Microcirculation endothelial cell cycling is selectively increased in antibody-mediated rejection of kidney transplants, but not in other diseases. Am J Transplant 2011; 11: 193 [s2].
71. Haas M, Mirocha J,. Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. Am J Transplant 2011; 11: 2123.
72. Reed EF, Demetris AJ, Hammond E, et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006; 25: 153.
73. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710.
74. Berry GJ, Angelini A, Burke MM, et al. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). J Heart Lung Transplant 2011; 30: 601.
75. Rodriguez ER, Tan CD,. Pathologic evaluation for antibody-mediated rejection: prognostic vs diagnostic markers? J Heart Lung Transplant 2011; 30: 136.
76. Drachenberg CB, Torrealba JR, Nankivell BJ, et al. Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema. Am J Transplant 2011; 11: 1792.
77. Glanville AR,. Antibody-mediated rejection in lung transplantation: myth or reality? J Heart Lung Transplant 2010; 29: 395.
78. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26: 1229.
79. Wallace WD, Reed EF, Ross D, Lassman CR, Fishbein MC,. C4d staining of pulmonary allograft biopsies: an immunoperoxidase study. J Heart Lung Transplant 2005; 24: 1565.
80. Saini D, Weber J, Ramachandran S, et al. Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant 2011; 30: 624.
81. Musat AI, Agni RM, Wai PY, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant 2011; 11: 500.
82. O'Leary JG, Kaneku H, Susskind BM, et al. High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant. Am J Transplant 2011; 11: 003A1868.
83. Ali S, Ormsby A, Shah V, et al. Significance of complement split product C4d in ABO-compatible liver allograft: Diagnosing utility in acute antibody mediated rejection. Transpl Immunol 2012; 26: 62.
84. Kozlowski T, Rubinas T, Nickeleit V, et al. Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies. Liver Transpl 2011; 17: 357.
85. Lunz J, Ruppert KM, Cajaiba MM, et al. Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring? Am J Transplant 2012; 12: 171.